Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Clinical trial NCT02978404 · COMPLETED

Trial details

NCT number: NCT02978404
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear-Cell Metastatic Renal Cell Carcinoma Non Small Cell Lung Cancer Metastatic Brain Metastases, Adult Small Cell Lung Cancer Melanoma

Start date: 2017-06-02
Primary completion: 2021-01-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.